Development and validation of the chemotherapy-induced peripheral neuropathy integrated assessment – oxaliplatin subscale: a prospective cohort study

BACKGROUND: Current chemotherapy-induced peripheral neuropathy (CIPN) assessment tools mostly have poor sensitivity and weak anti-interference, so that it is sometimes difficult to provide substantive guidance for clinical intervention. This study aimed to develop an assessment tool dedicated for ox...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Zhancheng, Chen, Chen, Gu, Jialin, Song, Ziwei, Wei, Guoli, Cai, Guoxiang, Shu, Qijin, Zhu, Lingjun, Zhu, Weiyou, Deng, Haibin, Li, Sheng, Chen, Aifei, Yin, Yue, Wu, Qiulan, Zhu, Hongyu, Li, Guochun, Dai, Anwei, Huo, Jiege
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648311/
https://www.ncbi.nlm.nih.gov/pubmed/37964212
http://dx.doi.org/10.1186/s12885-023-11541-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648311/
https://www.ncbi.nlm.nih.gov/pubmed/37964212
http://dx.doi.org/10.1186/s12885-023-11541-7

Ejemplares similares